Further analysis suggests that these worse survival outcomes may be due to increased aggressive cancer pathways, including epithelial–mesenchymal transition and hypoxia, along with decreased CD8+ and CD4+ T cell infiltration in high-PIEZO1 HR-negative tumors. This evidence concerns the gene CD4 and cancer.